Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction

Bibliography

• HENGARTNER MO: The biochemistry of apoptosis. Nature (2000) 407(6805):770–776.
   PubMed Web of Science ®Google Scholar
• SAVILL J, FADOK V: Corpse clearance defines the meaning of cell death. Nature (2000) 407(6805):784–788.
   PubMed Web of Science ®Google Scholar
• •• This paper is an extensive review of the different receptors involved in apoptotic cell uptake.
   Google Scholar
• SAVILL J, FADOK V, HENSON P, HASLETT C: Phagocyte recognition of cells undergoing apoptosis. Immunol. Today (1993) 14(3):131–136.
   PubMedGoogle Scholar
• OCHSENBEIN AF, KLENERMAN P, KARRER U et al: Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. USA (1999) 96(5):2233–2238.
   PubMed Web of Science ®Google Scholar
• MATZINGER ATZINGERP: Tolerance, danger, and the extended family. Ann. Rev. Immunol (1994) 12:991–1045.
   PubMed Web of Science ®Google Scholar
• •• Matzinger defined ‘danger’ as the major signal influencing immune response. Her viewpoint has refreshed tumour and transplantation immunology.
   Google Scholar
• GALLUCCI S, LOLKEMA M, MATZINGER P: Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. (1999) 5(11):1249–1255.
   PubMed Web of Science ®Google Scholar
• • Results illustrating the ‘danger’ theory (see [5]) are reported in this article. See also [71].
   Google Scholar
• RAFF MC: Social controls on cell survival and cell death. Nature (1992) 356(6368):397–400.
   PubMed Web of Science ®Google Scholar
• CASCIOLA-ROSEN LA, ANHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. (1994) 179(4): 1317–1330.
   PubMed Web of Science ®Google Scholar
• • This pioneering paper implicated a defect of apoptosis regulation in the development of autoimmunity.
   Google Scholar
• ALBERT ML, PEARCE SF, FRANCISCO LM et al.: Immature dendritic cells phagocytose apoptotic cells via alphav/beta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. (1998) 188(7):1359–1368.
   PubMed Web of Science ®Google Scholar
• ALBERT ML, SAUTER B, BHARDWAJ N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 392(6671):86–89. •• This first described the capture and the presentation of apoptotic cell-derived antigens by DCs. This paper is the foundation stone for proposing apoptotic cells as tumour vaccines. See also [9,13,19].
   Google Scholar
• YRLID U, WICK MJ: Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. (2000) 191 (4):613–624.
   PubMed Web of Science ®Google Scholar
• BELLONE M, IEZZI G, ROVERE P et al: Processing of engulfed apoptotic bodies yields T cell epitopes. J. Immunol. (1997) 159(11):5391–5399.
   PubMed Web of Science ®Google Scholar
• RONCHETTI A, ROVERE P, IEZZI G et al: Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol. (1999) 163(1): 130–136.
   PubMed Web of Science ®Google Scholar
• •• The different factors implicated in the immunogenicity of apoptotic cells are evaluated in this study. An efficient tumour vaccine is then built.
   Google Scholar
• HENRY F, BOISTEAU O, BRETAUDEAU L, LIEUBEAU B, MEFLAH K, GREGOIRE M: Antigen-presenting cells that phagocytose apoptotic tumor-derived cells are potent tumor vaccines. Cancer Res. (1999) 59(14):3329–3332.
   PubMed Web of Science ®Google Scholar
• FALO LD JR, KOVACSOVICS-BANKOWSKI M, THOMPSON K, ROCK KL: Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nat. Med. (1995) 1(7):649–653.
   PubMed Web of Science ®Google Scholar
• BONNOTTE B, FAVRE N, MOUTET M et al.: Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol. (1998) 161(3): 1433–1438.
   PubMed Web of Science ®Google Scholar
• •• An elegant illustration of the interaction between cell death, immunogenicity and tumourigenicity. As mentioned in the title, inhibition of apoptosis prevents immunogenicity, suggesting that tumour apoptosis in vivo is necessary to generate immune response. In their following article (see [106]), these authors suggest that tumour apoptotic materials are taken by phagocytes and guided to draining lymph nodes.
   Google Scholar
• BEVAN MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. (1976) 143(5): 1283–1288.
   PubMed Web of Science ®Google Scholar
• BROSSART P, BEVAN MJ: Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood (1997) 90(4):1594–1599.
   PubMed Web of Science ®Google Scholar
• INABA K, TURLEY S, YAMAIDE F et al.: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. (1998) 188(11):2163–2173. See [10].
   Google Scholar
• PONNER BB, STACH C, ZOLLER O et al: Induction of apoptosis reduces immunogenicity of human T-cell lines in mice. Scand. J. Immunol. (1998) 47(4):343–347.
   PubMed Web of Science ®Google Scholar
• SHRESTHA A, HORINO K, NISHIURA H, YAMAMOTO T: Acquired immune response as a consequence of the macrophage-dependent apoptotic cell clearance and role of the monocyte chemotactic S19 ribosomal protein dimer in this connection. Lab. Invest. (1999) 79 (12):1629–1642.
   PubMed Web of Science ®Google Scholar
• MEVORACH D, ZHOU JL, SONG X, ELKON KB: Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. (1998) 188(2): 387–392.
   PubMed Web of Science ®Google Scholar
• • This paper describes autoantibody production following massive infusion of apoptotic syngeneic thymocytes. The authors propose that an excess of apoptosis prone to autoimmunity. The results are a little bit overestimated when compared to mice genetically prone to lupus. However, the concept is very interesting.
   Google Scholar
• CHEN W, FRANK ME, JIN W, WAHL SM: TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity (2001) 14(6):715–725.
   PubMed Web of Science ®Google Scholar
• VOLL RE, HERRMANN M, ROTH EA, STACH C, KALDEN JR, GIRKONTAITE I: Immunosuppressive effects of apoptotic cells. Nature (1997) 390(6658):350–351. Letter. See [27].
   Google Scholar
• GAO Y, HERNDON JM, ZHANG H, GRIFFITH TS, FERGUSON TA: Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J. Exp. Med. (1998) 188(5):887–896.
   PubMed Web of Science ®Google Scholar
• GRIFFITH TS, YU X, HERNDON JM, GREEN DR, FERGUSON TA: CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity (1996) 5(1):7–16.
   PubMed Web of Science ®Google Scholar
• FADOK VA, BRATTON DL, KONOWAL A et al: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. (1998) 101 (4) :890–898.
   PubMed Web of Science ®Google Scholar
• •• Macrophages have the capacity to modulate the immune response after apoptotic cell uptake. This may be an additional security to avoid autoimmunity. The following papers of this team [28,67] are also very convincing and allow defining the role of macrophage as keeper of peripheral tolerance. See [24].
   Google Scholar
• FADOK VA, BRATTON DL, ROSE DM, PEARSON A, EZEKEWITZ RA, HENSON PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 405 (6782):85–90.
   PubMed Web of Science ®Google Scholar
• •• See [26]. This paper describes the characterisation of the PS R.
   Google Scholar
• FREIRE-DE-LIMA CG, NASCIMENTO DO, SOARES MB et al: Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature (2000) 403(6766):199–203.
   PubMed Web of Science ®Google Scholar
• BROWN SB, SAVILL J: Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J. Immunol. (1999) 162(1):480–485.
   PubMed Web of Science ®Google Scholar
• SAVILL J: Apoptosis. Phagocytic docking without shocking. Nature (1998) 392(6675):442–44 3.
   Google Scholar
• •• This is an interesting comment about receptors involved in apoptotic cell uptake and the subsequent signalling pathways.
   Google Scholar
• MARTH T, KELSALL BL: Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. (1997) 185(11):1987–1995.
   PubMed Web of Science ®Google Scholar
• SUTTERWALA FS, NOEL GJ, SALGAME P, MOSSER DM: Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor Type I. J. Exp. Med. (1998) 188(1):217–222.
   PubMed Web of Science ®Google Scholar
• BANCHEREAU J, STEINMAN RM: Dendritic cells and the control of immunity. Nature (1998) 392(6673):245–252.
   PubMed Web of Science ®Google Scholar
• •• An extensive review on DCs.
   Google Scholar
• GRABBE S, KAMPGEN E, SCHULER G: Dendritic cells: multi-lineal and multifunctional. Immunol. Today (2000) 21 (9): 431-433.
   Google Scholar
• •• A summary of the different functions and lineages of DCs.
   Google Scholar
• LANZAVECCHIA A, SALLUSTO F: The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin. Immunol. (2001) 13(3) :291–298.
   PubMed Web of Science ®Google Scholar
• SAAS P, TIBERGHIEN P: Dendritic cells: to where do they lead? Transplantaion (2002) 73(1) :S 12–S15.
   Google Scholar
• DHODAPKAR MV, STEINMAN RM, KRASOVSKY J, MUNZ C, BHARDWAJ N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. (2001) 193(2):233–238.
   PubMed Web of Science ®Google Scholar
• •• This paper is critical for tumour immunotherapy using DCs as adjuvants. Indeed, iDCs are responsible for tolerance induction. In contrast, this is an interesting approach to test in transplantation.
   Google Scholar
• ROVERE P, VALLINOTO C, BONDANZA A et al.: Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. (1998) 161 (9):4467–4471.
   PubMed Web of Science ®Google Scholar
• HAWIGER D, INABA K, DORSETT Y et al: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. (2001) 194(6):769–779.
   PubMed Web of Science ®Google Scholar
• • This paper gives more information on the role of DCs on tolerance.
   Google Scholar
• MODLIN RL: A Toll for DNA vaccines. Nature (2000) 408(6813):659–660.
   PubMed Web of Science ®Google Scholar
• BASU S, BINDER RJ, RAMALINGAM T, SRIVASTAVA PK: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity (2001) 14(3):303–313.
   PubMed Web of Science ®Google Scholar
• WAGNER H: Toll meets bacterial CpG-DNA. Immunity (2001) 14(5):499–502.
   PubMed Web of Science ®Google Scholar
• AKIRA S, TAKEDA K, KAISHO T: Tolllike receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. (2001) 2(8):675–680.
   PubMed Web of Science ®Google Scholar
• ISHII KJ, SUZUKI K, COBAN C et al: Genomic DNA released by dying cells induces the maturation of APCs. J. Immunol. (2001) 167(5):2602–2607.
   PubMed Web of Science ®Google Scholar
• • Mammalian DNA can cause DC maturation. This suggests that released DNA can be a ‘danger’ signal in the absence of quick removal or degradation.
   Google Scholar
• DE CARVALHO BITTENCOURT M, SAAS P, FRESNAY S et al: Exposure to exogenous DNA can modify the sensitivity of the Fas apoptotic pathway. J. Gene Med. (2002). 4(1): 14–24.
   PubMed Web of Science ®Google Scholar
• HUANG FP, PLATT N, WYKES M et al: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. (2000) 191(3):435–444.
   PubMed Web of Science ®Google Scholar
• •• This fascinating paper provides an additional mechanism for peripheral tolerance. A subpopulation of DCs may be dedicated to capture antigens from apoptotic normal tissue in the periphery and to inactivate self-antigen reactive T-lymphocytes in lymph node.
   Google Scholar
• PARNAIK R, RAFF MC, SCHOLES J: Differences between the clearance of apoptotic cells by professional and nonprofessional phagocytes. Curr. Biol. (2000) 10(14):857–860.
   PubMed Web of Science ®Google Scholar
• WALSH GM, SEXTON DW, BLAYLOCK MG, CONVERY CM: Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. Blood (1999) 94(8):2827–2835.
   PubMed Web of Science ®Google Scholar
• DINI L, LENTINI A, DIEZ GD et al: Phagocytosis of apoptotic bodies by liver endothelial cells. J. Cell. Sci. (1995) 108(3):967–973.
   PubMedGoogle Scholar
• FADOK VA, BRATTON DH, HENSON PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. (2001) 108(7):957–962.
   PubMed Web of Science ®Google Scholar
• LOPES MF, FREIRE-DE-LIMA CG, DOSREIS GA et al.: The macrophage haunted by cell ghosts: a pathogen grows. Immunol. Today (2000) 21(10):489–494.
   PubMedGoogle Scholar
• URBAN BC, WILLCOX N, ROBERTS DJ: A role for CD 36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA (2001) 98(15):8750–8755.
   PubMed Web of Science ®Google Scholar
• • A receptor involved in apoptotic cell uptake is also capable to inhibit DC maturation. This concept is interesting and will certainly generate more studies on this aspect.
   Google Scholar
• GALATI G, ROVERE P, CITTERIO G et al: In vivo administration of GM-CSF promotes the clearance of apoptotic cells: effects on monocytes and polymorphonuclear leukocytes. J. Leukoc. Biol. (2000) 67(2):174–182.
   PubMed Web of Science ®Google Scholar
• STREILEIN JW: Unraveling immune privilege. Science (1995) 270(5239): 1158–1159.
   PubMed Web of Science ®Google Scholar
• ROVERE P, MANFREDI AA, VALLINOTO C et al.: Dendritic cells preferentially internalize apoptotic cells opsonized by anti-beta2-glycoprotein I antibodies. J. Autoimmun. (1998) 11 (5) :403–411.
   PubMed Web of Science ®Google Scholar
• LEVINE JS, SUBANG R, KOH JS, RAUCH J: Induction of anti-phospholipid autoantibodies by beta2-glycoprotein I bound to apoptotic thymocytes. J. Autoimmun. (1998) 11 (5):413–424.
   PubMed Web of Science ®Google Scholar
• ROVERE P, SABBADINI MG, VALLINOTO C et al.: Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies. Arthritis Rheum. (1999) 42(7): 1412–1420.
   PubMed Web of Science ®Google Scholar
• ROVERE P, PERI G, FAZZINI F et al: The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood (2000) 96(13):4300–4306.
   PubMed Web of Science ®Google Scholar
• • See [60–62].
   Google Scholar
• BICKERSTAFF MCM, BOTTO M, HUTCHINSON WL et al: Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. (1999) 5(6) :694–697.
   PubMed Web of Science ®Google Scholar
• • See [59, 61, 62].
   Google Scholar
• FAMILIAN A, ZWART B, HUISMAN HG et al: Chromatin-independent binding of serum amyloid P component to apoptotic cells. J. Immunol. (2001) 167(2):647–654.
   PubMed Web of Science ®Google Scholar
• • See [59–62].
   Google Scholar
• GERSHOV D, KIM S, BROT N, ELKON KB: C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. (2000) 192 (9): 1353–1364. Published erratum in J. Exp. Med. (2001) 193(12):1439.
   Google Scholar
• • See [59-61]. Some acute phase proteins have the capacities to bind apoptotic cells and to modify the capture of such cells. In general, these acute phase proteins have an anti-inflammatory effect that prevents unwanted efficient immune response.
   Google Scholar
• MEVORACH D, MASCARENHAS JO, GERSHOV D, ELKON KB: Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. (1998) 188(12) :2313–2 320.
   Google Scholar
• KORB LC, AHEARN JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. (1997) 158(10):4525–4528.
   PubMed Web of Science ®Google Scholar
• BOTTO M, DELL’AGNOLA C, BYGRAVE AE et al.: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. (1998) 19(1):56–59.
   PubMed Web of Science ®Google Scholar
• TAYLOR PR, CARUGATI A, FADOK VA et al.: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. (2000) 192(3):359–366.
   PubMed Web of Science ®Google Scholar
• OGDEN CA, DECATHELINEAU A, HOFFMANN PR et al: C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. (2001) 194(6):781–795.
   PubMed Web of Science ®Google Scholar
• • This elegant article describes a new clearance pathway for apoptotic cells. A complex associating different partners (apoptotic cell, the first protein of the complement C1q and a soluble protein calreticulin) interacts with the receptor in fashion, CD91. Indeed, this receptor is also the receptor for Hsps.
   Google Scholar
• WALPORT MJ: Complement. N. Engl. J. Med. (2001) 344(15): 1140–1144.
   PubMed Web of Science ®Google Scholar
• REITER I, KRAMMER B, SCHWAMBERGER G: Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J. Immunol. (1999) 163(4):1730–1732.
   PubMed Web of Science ®Google Scholar
• SALIO M, CERUNDOLO V, LANZAVECCHIA A: Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur. J. Immunol. (2000) 30(2): 705–708.
   PubMed Web of Science ®Google Scholar
• SAUTER B, ALBERT ML, FRANCISCO L, LARSSON M, SOMERSAN S, BHARDWAJ N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. (2000) 191 (3):423–434.
   PubMed Web of Science ®Google Scholar
• • This is one of the initial papers describing DC maturation following necrotic tumour cells. In contrast, necrotic cells from normal tissues do not induce such maturation.
   Google Scholar
• PIETRA G, MORTARINI R, PARMIANI G, ANICHINI A: Phases of apoptosis of melanoma cells, but not of normal melanocytes, differently affect maturation of myeloid dendritic cells. Cancer Res. (2001) 61 (22):8218–8226.
   PubMed Web of Science ®Google Scholar
• FADOK VA, BRATTON DL, GUTHRIE L, HENSON PM: Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. (2001) 166(11):6847–6854.
   PubMed Web of Science ®Google Scholar
• BASU S, BINDER RJ, SUTO R, ANDERSON KM, SRIVASTAVA PK: Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. (2000) 12(11):1539–1546.
   PubMed Web of Science ®Google Scholar
• MELCHER A, TODRYK S, HARD WICK N, FORD M, JACOBSON M, VILE RG: Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. (1998) 4(5):581–587.
   PubMed Web of Science ®Google Scholar
• •• In 1998, this paper stimulated the authors not to consider apoptosis as a cell death mechanism ignored by the adaptive immune system. It was also novel for them that cell death is not just a mechanism to stop an immune response (AICD for example). In addition, physiological apoptotic cell death has to be distinguished from accidental necrosis. The role of Hsps in immunogenicity is elegantly addressed using the suicide gene approach. See [76].
   Google Scholar
• TODRYK S, MELCHER AA, HARD WICK N et al.: Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. (1999) 163 (3): 1398–1408.
   Google Scholar
• • This is the second part of the story ‘heat shock protein and immunogenicity’, see [75].
   Google Scholar
• LI M, CARPIO DF, ZHENG Y et al: An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. (2001) 166(12):7128–7135.
   PubMed Web of Science ®Google Scholar
• • Here, the authors describe an interesting link between a ‘dangerous’ cell death mechanism necrosis and a family of ‘danger’ receptors, namely the TLRs.
   Google Scholar
• FENG H, ZENG Y, WHITESELL L, KATSANIS E: Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood (2001) 97(11):3505–3512.
   PubMed Web of Science ®Google Scholar
• • This is the third part of the story ‘heat shock proteins, stress and immunogenicity’. See [75,76].
   Google Scholar
• COCCO RE, UCKER DS: Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidyl serine exposure. Mol. Biol. Cell. (2001) 12(4):919–930.
   PubMed Web of Science ®Google Scholar
• FUJII C, SHIRATSUCHI A, MANAKA J, YONEHARA S, NAKANISHI Y: Difference in the way of macrophage recognition of target cells depending on their apoptotic states. Cell. Death Differ. (2001) 8(11): 1113–1122.
   PubMed Web of Science ®Google Scholar
• CHUNG S, GUMIENNY TL, HENGARTNER MO, DRISCOLL M: A common set of engulfment genes mediates removal of both apoptotic and necrotic cell corpses in C. elegans. Nat. Cell. Biol. (2000) 2(12):931–937.
   PubMed Web of Science ®Google Scholar
• HIRT UA, GANTNER F, LEIST M: Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms. J. Immunol. (2000) 164(12):6520–6529.
   PubMed Web of Science ®Google Scholar
• GAIPL US, KUENKELE S, VOLL RE et al: Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell. Death Differ. (2001) 8(4):327–334.
   PubMed Web of Science ®Google Scholar
• LEIST M, SINGLE B, CASTOLDI AF, KUHNLE S, NICOTERA P: Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. (1997) 185(8): 1481–1486.
   PubMed Web of Science ®Google Scholar
• FISHELSON Z, ATTALI G, MEVORACH D: Complement and apoptosis. Mol. Immunol. (2001) 38(2-3):207–219.
   PubMed Web of Science ®Google Scholar
• PROPATO A, CUTRONA G, FRANCAVILLA V et al: Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat. Med. (2001) 7(7):807–813.
   PubMed Web of Science ®Google Scholar
• •• Expression of stimulating molecules (here, CD40L) by apoptotic cells induces DC maturation. This adds a level of complexity. Before this paper, it was sufficient to dissociate normal tissue and tumour. Now, the differentiation stage of a similar cell may influence the outcome.
   Google Scholar
• WALKER PR, SAAS P, DIETRICH PY Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J. Immunol. (1997) 158(10):4521–4524.
   PubMed Web of Science ®Google Scholar
• CHAUX P, FAVRE N, MARTIN M, MARTIN F: Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer. (1997) 72(4):619–624.
   PubMed Web of Science ®Google Scholar
• BELL D, CHOMARAT P, BROYLES D et al: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med. (1999) 190(10):1417–1426.
   PubMed Web of Science ®Google Scholar
• KIERTSCHER SM, LUO J, DUBINETT SM, ROTH MD: Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. (2000) 164(3):1269–1276.
   PubMed Web of Science ®Google Scholar
• NOURI-SHIRAZI M, BANCHEREAU J, BELL D et al.: Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. (2000) 165(7):3797–3803.
   PubMed Web of Science ®Google Scholar
• DE CARVALHO BITTENCOURT M, PERRUCHE S, CONTASSOT E et al: Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood (2001) 98(1):224–230.
   PubMed Web of Science ®Google Scholar
• •• This paper addresses for the first time the use of apoptotic cells for tolerance induction. The immunomodulatory properties of apoptotic cells are used to inhibit host immune response. Some questions are still arising, such as the involved mechanism.
   Google Scholar
• LI H, YUAN J: Deciphering the pathways of life and death. Curr. Opin. Cell Biol. (1999) 11(2):261–266.
   PubMed Web of Science ®Google Scholar
• SCAFFIDI C, FULDA S, SRINIVASAN A et al: Two CD95 (APO-1/Fas) signaling pathways. EMBO J. (1998) 17(6): 1675–1687.
   PubMed Web of Science ®Google Scholar
• BELLONE M: Apoptosis, cross-presentation, and the fate of the antigen specific immune response. Apoptosis (2000) 5 (4): 307–314.
   PubMed Web of Science ®Google Scholar
• •• An interesting review discussing the immunogenicity of apoptotic cells. The authors propose that the pro-apoptotic stimulus may influence apoptotic cell uptake, protein degradation, peptide trafficking, peptide association with MHC molecules and finally antigen presentation. This is a way to explore.
   Google Scholar
• PACZESNY S, BERANGER S, SALZMANN JL, KLATZMANN D, COLOMBO BM: Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells. Cancer Res. (2001) 61(6):2386–2389.
   PubMed Web of Science ®Google Scholar
• BERARD F, BLANCO P, DAVOUST J et al: Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J. Exp. Med. (2000) 192(11):1535–1544.
   PubMed Web of Science ®Google Scholar
• JENNE L, ARRIGHI JF, JONULEIT H, SAURAT JH, HAUSER C: Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Cancer Res. (2000) 60(16):4446–4452.
   PubMed Web of Science ®Google Scholar
• RUSSO V, TANZARELLA S, DALERBA P et al.: Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response. Proc. Natl. Acad. Sci. USA (2000) 97(5):2185–2190.
   PubMed Web of Science ®Google Scholar
• SHAIF-MUTHANA M, MCINTYRE C, SISLEY K, RENNIE I, MURRAY A: Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res. (2000) 60(22):6441–6447.
   PubMed Web of Science ®Google Scholar
• CHATTERGOON MA, KIM JJ, YANG JS et al.: Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nat. Biotechnol. (2000) 18(9):974–979. This paper elegantly demonstrates that favouring APC apoptosis increases antigen transfer and immunogenicity.
   Google Scholar
• HENRY F, BRETAUDEAU L, BARBIEUX I, MEFLAH K, GREGOIRE M: Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. Res. Immunol. (1998) 149(7-8):673–679.
   PubMedGoogle Scholar
• HEATH WR, CARBONE FR: Cross-presentation, dendritic cells, tolerance and immunity. Ann. Rev. Immunol. (2001) 19:47–64.
   PubMed Web of Science ®Google Scholar
• ••This is a brilliant review on cross-presentation and cross-tolerance.
   Google Scholar
• RENZ A, BERDEL WE, KREUTER M, BELKA C, SCHULZE-OSTHOFF K, LOS M: Rapid extracellular release of cytochrome c is specific for apoptosis and marks cell death in vivo. Blood (2001) 98(5):1542–1548.
   PubMed Web of Science ®Google Scholar
• BARKER FG, DAVIS RL, CHANG SM, PRADOS MD: Necrosis as a prognostic factor in glioblastoma multiforme. Cancer (1996) 77(6):1161–1166.
   PubMed Web of Science ®Google Scholar
• BONNOTTE B, FAVRE N, MOUTET M et al.: Role of tumor cell apoptosis in tumor antigen migration to the draining lymph nodes. J. Immunol. (2000) 164(4):1995–2000.
   PubMed Web of Science ®Google Scholar
• ••See [16].
   Google Scholar
• BERGER CL, XU AL, HANLON D et al.: Induction of human tumor-loaded dendritic cells. Int. J. Cancer. (2001) 91 (4): 438-447.
   Google Scholar
• BONNOTTE B, LARMONIER N, FAVRE N et al: Identification of tumor-infiltrating macrophages as the killers of tumor cells after immunization in a rat model system. J. Immunol. (2001) 167(9) :5077–5083.
   PubMed Web of Science ®Google Scholar
• LUDEWIG B, MCCOY K, PERICIN M et al: Rapid peptide turnover and inefficient presentation of exogenous antigen critically limit the activation of self-reactive CTL by dendritic cells. J. Immunol. (2001) 166(6): 3678–3687.
   PubMed Web of Science ®Google Scholar
• FUJITA N, KAGAMU H, YOSHIZAWA H et al: CD40 Ligand promotes priming of fully potent antitumor CD4(+) T cells in draining lymph nodes in the presence of apoptotic tumor cells. J. Immunol. (2001) 167(10) :5678–5 688.
   Google Scholar
• •• This paper is interesting in two aspects. Firstly, it confirms that apoptotic cells alone are not a good approach to vaccine against tumour. Secondly, it also excludes necrosis as a sufficient ‘danger’ signal. In contrast, CD40L expressing viable tumour cells in a limited amount are sufficient to prime antitumour specific T-cells.
   Google Scholar
• HIRAO M, ONAI N, HIROISHI K et al.: CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res. (2000) 60(8):2209–2217.
   PubMed Web of Science ®Google Scholar
• RUSSO V, ZHOU D, SARTIRANA C et al: Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells. Blood (2000) 95(11):3473–3477.
   PubMed Web of Science ®Google Scholar
• • See [113].
   Google Scholar
• HARSHYNE LA, WATKINS SC, GAMBOTTO A, BARRATT-BOYES SM: Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. (2001) 166(6):3717–3723. Published Erratum in J. Immunol. (2001) 166(9):5840.
   Google Scholar
• • These two papers [112,113] are disconcerting, but also very interesting. In a very provocative manner, they make us ask the question about the necessity to use dying tumour cells to favour antitumour immune response. Indeed, non-replicative tumour cells have been previously reported [13] as the most efficient approach to generate antitumour immune response.
   Google Scholar
• CASCIOLA-ROSEN L, ANDRADE F, ULANET D, WONG WB, ROSEN A: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. (1999) 190(6):815–826.
   PubMed Web of Science ®Google Scholar
• GUINAN EC, BOUSSIOTIS VA, NEUBERG D et al: Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. (1999) 340(22): 1704–1714.
   PubMed Web of Science ®Google Scholar
• DE CARVALHO BITTENCOURT M, TIBERGHIEN P, SAAS P: Transplantation of anergic histoincompatible bone marrow cells. N. Engl. J. Med. (1999) 341 (14): 1081–1082. Letter to the Editor.
   Google Scholar
• KURTS C, MILLER JF, SUBRAMANIAM RM, CARBONE FR, HEATH WR: Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. (1998) 188(2):409–414.
   PubMed Web of Science ®Google Scholar
• KURTS C, SUTHERLAND RM, DAVEY G et al: CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA (1999) 96(22): 12703–12707.
   PubMed Web of Science ®Google Scholar
• TAN IGAWA T, GOTOH M, NAGANO H et al: Injection of mitomycin-C-treated spleen cells induces donor-specific unresponsiveness to cardiac allografts in rats. Transplantation (1999) 67(5):653–658.
   PubMed Web of Science ®Google Scholar
• TSUI TY, DEIWICK A, KO S, SCHLITT HJ: Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft- versus-host reactivity. Transplana tion (2000) 69(1):25–30.
   PubMed Web of Science ®Google Scholar
• KLEINCLAUSS F, PERRUCHE S, ANGONIN R et al: Intravenous infusion of apoptotic leukocytes facilitates allogeneic hematopoietic cell engraftment after a non myeloablative conditioning regimen and induces tolerance to donor antigens. The 43rd Annual Meeting of the American Society of Hematology (2001) Orlando, USA. Abstract published in Blood (2001) 98(11):735a.
   Google Scholar
• GALLUCCI S, MATZINGER P: Danger signals: SOS to the immune system. Curr Opin. Immunol. (2001) 13(1): 114–119.
   PubMed Web of Science ®Google Scholar
• •• A recent review on ‘danger’.
   Google Scholar
• RESTIFO NP: Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr. Opin. Immunol. (2000) 12 (5): 597-603.
   Google Scholar
• •• A very interesting paper dealing with antitumour vaccines.
   Google Scholar
• KOTERA Y, SHIMIZU K, MULE JJ: Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. (2001) 61 (22) :8105–8109.
   PubMed Web of Science ®Google Scholar
• GAUTIER F, IRMINGER-FINGER I, GREGOIRE M, MEFLAH K, HARB J: Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies. Cancer Res. (2000) 60(24):6895–6900.
   PubMed Web of Science ®Google Scholar
• LUDEWIG B, OCHSENBEIN AF, ODERMATT B, PAULIN D, HENGARTNER H, ZINKERNAGEL RM: Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. (2000) 191 (5):795–804.
   PubMed Web of Science ®Google Scholar
• VAN ELSAS A, SUTMULLER RP, HURWITZ AA et al: Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J. Exp. Med. (2001) 194(4):481–489.
   PubMed Web of Science ®Google Scholar
• • This paper gives some answers about the question of autoimmunity induced following antitumour immunotherapy.
   Google Scholar
• REGNAULT A, LANKAR D, LACABANNE V et al.: Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. (1999) 189 (2):371–380.
   PubMed Web of Science ®Google Scholar
• NESTLE FO, BANCHEREAU J, HART D: Dendritic cells: On the move from bench to bedside. Nat. Med. (2001) 7(7): 761–765.
   PubMed Web of Science ®Google Scholar
• • An useful paper for teams working with DCs in clinical trials.
   Google Scholar
• OHSHIMA Y, TANAKA Y, TOZAWA H, TAKAHASHI Y, MALISZEWSKI C, DELESPESSE G: Expression and function of OX40 ligand on human dendritic cells. J. Immunol. (1997) 159(8):3838–3848.
   PubMed Web of Science ®Google Scholar
• MOREL Y, TRUNEH A, SWEET RW, OLIVE D, COSTELLO RT The TNF superfamily members LIGHT and CD 154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. (2001) 167(5):2479-2486.
   Google Scholar
• KANTO T, KALINSKI P, HUNTER OC, LOTZE MT, AMOSCATO AA: Ceramide mediates tumor-induced dendritic cell apoptosis. J. Immunol. (2001) 167(7):3773–3784.
   PubMed Web of Science ®Google Scholar
• DEMEURE CE, TANAKA H, MATEO V, RUBIO M, DELESPESSE G, SARFATI M: CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. (2000) 164(4):2193–2199.
   PubMed Web of Science ®Google Scholar
• JONULEIT H, SCHMITT E, SCHULER G, KNOP J, ENK AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. (2000) 192(9):1213–1222.
   PubMed Web of Science ®Google Scholar
• •• This confirms a role for iDCs in peripheral tolerance.
   Google Scholar
• SHEVACH EM: Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. (2001) 193(11):F41–F46.
   PubMed Web of Science ®Google Scholar
• SUTMULLER RP, VAN DUIVENVOORDE LM, VAN ELSAS A et al: Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med. (2001) 194(6):823–832.
   PubMed Web of Science ®Google Scholar